Cardiovascular
Coronary Artery Ectasia
0
Pipeline Programs↗
0
Active Trials↗
0
Companies Involved↗
Coronary Artery Ectasia is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
3
clinical trials
Completed2 · 67%
Unknown status1 · 33%
Clinical Trials
Trial Activity
Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.
Unknown status·—·Phase 3·NCT05718531·200 enrolled
Coronary Artery Ectasia in Elective Coronary Angiography : Predictors, Outcomes and Management
Completed·—·N/A·NCT03896321·79 enrolled
Effect of Diltiazem on Coronary Artery Ectasia
Completed·—·N/A·NCT02024919·60 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)